Mariotto, Sara
 Distribuzione geografica
Continente #
NA - Nord America 4.181
AS - Asia 3.200
EU - Europa 2.824
SA - Sud America 589
AF - Africa 75
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 10.899
Nazione #
US - Stati Uniti d'America 4.111
SG - Singapore 1.221
CN - Cina 1.080
BR - Brasile 515
GB - Regno Unito 496
IT - Italia 462
HK - Hong Kong 383
RU - Federazione Russa 360
DE - Germania 297
IE - Irlanda 291
SE - Svezia 289
FR - Francia 286
FI - Finlandia 146
VN - Vietnam 141
KR - Corea 128
ID - Indonesia 46
CA - Canada 37
UA - Ucraina 37
JP - Giappone 35
IN - India 32
AR - Argentina 31
TG - Togo 29
BE - Belgio 28
AT - Austria 27
NL - Olanda 26
AU - Australia 25
IR - Iran 23
ES - Italia 21
ZA - Sudafrica 21
MX - Messico 18
TR - Turchia 18
BD - Bangladesh 15
EC - Ecuador 10
LT - Lituania 10
PL - Polonia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
IQ - Iraq 9
SA - Arabia Saudita 8
CL - Cile 7
PK - Pakistan 7
UZ - Uzbekistan 7
CO - Colombia 5
CZ - Repubblica Ceca 5
IL - Israele 5
JM - Giamaica 5
KE - Kenya 5
MA - Marocco 5
BG - Bulgaria 4
LB - Libano 4
LU - Lussemburgo 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
TW - Taiwan 4
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
ML - Mali 2
PS - Palestinian Territory 2
TH - Thailandia 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NI - Nicaragua 1
Totale 10.892
Città #
Dallas 704
Chandler 674
Singapore 534
Southend 403
Hong Kong 381
Ashburn 346
Dublin 277
Beijing 236
Verona 147
Woodbridge 145
Jacksonville 127
New York 122
Lawrence 96
Princeton 96
Ann Arbor 93
Los Angeles 88
Wilmington 83
Helsinki 72
Munich 71
Jinan 70
Dearborn 66
Redondo Beach 59
The Dalles 59
Houston 56
Shenyang 54
Redmond 53
Sindelfingen 52
Nanjing 51
Buffalo 43
Hebei 43
Columbus 40
Jakarta 40
Washington 37
Dong Ket 36
Milan 34
Santa Clara 34
São Paulo 32
Tianjin 32
Seoul 31
Seattle 30
Lomé 29
Nuremberg 28
Boardman 27
Brussels 27
Ningbo 27
Changsha 26
Guangzhou 25
Lappeenranta 25
Ho Chi Minh City 24
Tokyo 24
Chicago 23
Hangzhou 23
Adelaide 22
Bologna 22
Turku 22
Brooklyn 21
Falls Church 21
Nanchang 21
Zhengzhou 21
Taiyuan 20
Kent 18
London 18
Council Bluffs 17
Haikou 17
Moscow 17
Phoenix 17
Belo Horizonte 16
Redwood City 16
Rio de Janeiro 16
Norwalk 15
Taizhou 15
Bloomsbury 13
Frankfurt am Main 13
Hanoi 13
Vienna 13
Campinas 12
Brasília 11
Fairfield 11
Menlo Park 11
Toronto 11
Dongguan 10
Florence 10
Jiaxing 10
Montreal 10
Boston 9
Hefei 9
Johannesburg 9
Lanzhou 9
San Francisco 9
Falkenstein 8
Lancaster 8
Mexico City 8
Warsaw 8
Fortaleza 7
Fuzhou 7
Paris 7
Rome 7
Salvador 7
Valencia 7
Amsterdam 6
Totale 6.580
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 175
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 162
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 161
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 159
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 151
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 151
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 150
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 143
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 139
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 136
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 134
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 133
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 131
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 129
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 129
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 129
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 128
Brentuximab vedotin: axonal microtubule's Apollyon 122
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 114
HCV-related nervous system disorders. 113
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 110
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 109
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 108
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 107
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 106
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 105
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 104
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 103
Nervous system: subclinical target of SARS-CoV-2 infection 103
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 103
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 102
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 101
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 101
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 99
Oligoclonal bands: clinical utility and interpretation cues 99
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 99
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 98
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 98
l-dopa-induced off: functional overlay in Parkinson disease 97
Gender disparity in editorial boards of journals in neurology 95
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 94
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 94
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 93
Cerebrospinal fluid analysis and the determination of oligoclonal bands 93
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 92
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 89
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 89
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 89
Autoimmune encephalitis: a retrospective monocentric experience 89
Infectious neuropathies 88
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 87
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 87
Anti-MOG-associated demyelinating disorders: two sides of the same coin 87
Inter-center agreement in the interpretation of oligoclonal bands 86
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 85
HCV-related central and peripheral nervous system demyelinating disorders. 83
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 83
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 83
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 82
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 81
Diagnostics of dysimmune peripheral neuropathies 81
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 80
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 78
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 77
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 77
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 77
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 76
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 75
Diagnostics of anti-MAG antibody polyneuropathy 74
Diagnostics of paraneoplastic neurological syndromes 74
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 73
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 73
Exposure to TNF inhibitors is rare at MOGAD presentation 73
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 71
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 71
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 70
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 70
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 69
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 69
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 69
Is there a correlation between MOGAD and SARS-CoV-2 infection? 69
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 67
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 67
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases 66
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 65
Serum neurofilament light chain studies in neurological disorders, hints for interpretation 65
Autoimmune encephalitis misdiagnosis and mimics 63
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 63
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 62
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 62
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 62
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study 60
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 59
Peripheral neuropathy and central nervous system involvement in cryoglobulinemia 59
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 59
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 58
Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers 58
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 57
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study 57
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 57
Totale 9.302
Categoria #
all - tutte 50.222
article - articoli 49.206
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 355
patent - brevetti 0
selected - selezionate 0
volume - volumi 661
Totale 100.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 81 67 61 27 17 45 9 73 69
2021/2022839 54 260 2 114 19 32 14 36 31 37 70 170
2022/20231.896 112 186 156 334 141 458 23 129 225 33 61 38
2023/20241.257 47 79 135 135 109 299 55 76 20 68 166 68
2024/20253.138 147 196 118 487 154 116 182 195 531 244 255 513
2025/20262.074 636 671 634 133 0 0 0 0 0 0 0 0
Totale 11.164